Cargando…
Efficiency and safety of one-year anti-TNF-α treatment in Crohn’s disease: a Polish single-centre experience
INTRODUCTION: Anti-TNF-α therapy of Crohn’s disease (CD) represents considerable progress in inflammatory bowel disease (IBD) treatment; however, many patients still require surgical intervention. The Polish National Insurance Fund currently only covers up to 2 years of infliximab (IFX) therapy in C...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Termedia Publishing House
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7294981/ https://www.ncbi.nlm.nih.gov/pubmed/32550949 http://dx.doi.org/10.5114/pg.2019.90079 |